➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Dow
Boehringer Ingelheim
McKinsey
Express Scripts

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

FLEXICORT Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Flexicort, and what generic alternatives are available?

Flexicort is a drug marketed by Westwood Squibb and is included in one NDA.

The generic ingredient in FLEXICORT is hydrocortisone. There are sixty-seven drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.

US ANDA Litigation and Generic Entry Outlook for Flexicort

A generic version of FLEXICORT was approved as hydrocortisone by IMPAX LABS INC on March 30th, 2007.

  Start Trial

Summary for FLEXICORT
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 94
Formulation / Manufacturing:see details
DailyMed Link:FLEXICORT at DailyMed
Drug patent expirations by year for FLEXICORT

US Patents and Regulatory Information for FLEXICORT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Westwood Squibb FLEXICORT hydrocortisone CREAM;TOPICAL 087136-003 Apr 8, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Westwood Squibb FLEXICORT hydrocortisone CREAM;TOPICAL 087136-002 Apr 8, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Westwood Squibb FLEXICORT hydrocortisone CREAM;TOPICAL 087136-001 Apr 8, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Merck
Colorcon
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.